We could not find any results for:
Make sure your spelling is correct or try broadening your search.
SOLARVEST ANNOUNCES MANAGEMENT CHANGES Canada NewsWire VANCOUVER, BC, Oct. 31, 2023 /NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR RELEASE, PUBLICATION, DISTRIBUTION OR...
SOLARVEST ANNOUNCES WITHDRAWAL OF SHAREHOLDER REQUISITION AND DIRECTOR CHANGES Canada NewsWire VANCOUVER, BC, Oct. 18, 2023 /NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR...
Suspension de la négociation par l'Organisme canadien de réglementation des investissements - SVS Canada NewsWire VANCOUVER, BC, le 5 sept. 2023 VANCOUVER, BC, le 5 sept. 2023 /CNW/...
Canadian Investment Regulatory Organization Trading Halt - SVS Canada NewsWire VANCOUVER, BC, Sept. 5, 2023 VANCOUVER, BC, Sept. 5, 2023 /CNW/ - The following issues have been halted by...
L'OCRCVM permet la reprise de la négociation - SVS Canada NewsWire VANCOUVER, BC, le 20 avril 2023 VANCOUVER, BC, le 20 avril 2023 /CNW/ - Reprise des négociations pour : Société :...
IIROC Trading Resumption - SVS Canada NewsWire VANCOUVER, BC, April 20, 2023 VANCOUVER, BC, April 20, 2023 /CNW/ - Trading resumes in: Company: Solarvest BioEnergy Inc. TSX-Venture Symbol:...
Suspension de la négociation par l'OCRCVM - SVS Canada NewsWire VANCOUVER, BC, le 19 avril 2023 VANCOUVER, BC, le 19 avril 2023 /CNW/ - L'OCRCVM a suspendu la négociation des titres...
IIROC Trading Halt - SVS Canada NewsWire VANCOUVER, BC, April 19, 2023 VANCOUVER, BC, April 19, 2023 /CNW/ - The following issues have been halted by IIROC: Company: Solarvest BioEnergy...
FSD Pharma Inc. (NASDAQ: HUGE) (CSE: HUGE) (FRA: 0K9A) (“FSD Pharma”) and Solarvest BioEnergy Inc. (TSX-V: SVS) (“Solarvest”) (collectively, the “Parties”), are pleased to announce that, further...
FSD PHARMA ANNOUNCES SIGNING OF LOI WITH SOLARVEST TO DEVELOP AND TEST PHARMA-GRADE CANNABINOIDS OUT OF ALGAE PHARMA GRADE PROCESS COULD REDUCE THE PRODUCTION TIME FOR...
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
4 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
12 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
26 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
52 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
156 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
260 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions